Skip to main content
Clinical Trials/NCT01808105
NCT01808105
Completed
N/A

Growth and Tolerance of Young Infants Fed Infant Formulas

Abbott Nutrition25 sites in 2 countries424 target enrollmentApril 2013

Overview

Phase
N/A
Intervention
Not specified
Conditions
Growth and Tolerance
Sponsor
Abbott Nutrition
Enrollment
424
Locations
25
Primary Endpoint
Weight
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

To evaluate growth and tolerance of healthy term infants fed experimental infant formulas, a commercial infant formula and human breast milk.

Registry
clinicaltrials.gov
Start Date
April 2013
End Date
February 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Singleton from full term birth with a gestational age 37-42 weeks
  • Birth weight \> 2490 g (\~5 lbs 8 oz)
  • Between 0 and 5 days of age
  • Smoke-free home (no smoking in the house dwelling), and mothers in the breast-fed group are prohibited from smoking during the study period
  • Parent(s) of formula-fed infants have elected not to breastfeed and confirm that their infant has been exclusively formula-fed since birth and confirm their intention is to exclusively feed their infant study infant formula for the duration of the study,
  • Parent(s) of human milk-fed infants have elected to breastfeed and confirm that their infant has been exclusively human milk-fed (not donor milk) since birth and confirm their intention is to continue to exclusively feed human milk with vitamin/mineral supplementation for the duration of the study
  • No administration vitamin or mineral supplements (excluding vitamin or mineral supplements containing vitamin D, if recommended by a healthcare professional), solid foods or juices to infants from enrollment through the duration of the study, unless instructed otherwise by their healthcare professional

Exclusion Criteria

  • Adverse maternal, fetal or infant medical history that has potential effects on tolerance, growth, and/or development
  • Infants using medications, home remedies, herbal preparations, probiotics or rehydration fluids that might affect gastrointestinal (GI) tolerance may not be enrolled
  • Treatment with antibiotics
  • Mother intends to use a combination of breast and formula feeding

Outcomes

Primary Outcomes

Weight

Time Frame: Study Day (SD) 14 - 119

Weight gain per day

Secondary Outcomes

  • Length(Study Day (SD) 1, 14, 28, 42, 84 and 119 visits)
  • Stool Characteristics(Study Day (SD) 1-28; 3 Day Records prior to SD 42, 84 and 119 visits)
  • Feeding Tolerance(Study Day (SD) 1-28; 3 Day Records prior to SD 42, 84 and 119 visits)
  • Head Circumference(Study Day (SD) 1, 14, 28, 42, 84 and 119 visits)

Study Sites (25)

Loading locations...

Similar Trials